J.-Y. Reginster - Concepedia

Author

J.-Y. Reginster

Also Known As

J Y Reginster, J. -Y. Reginster, J. Y. REGINSTER, J.-Y. Reginster, J.Y Reginster, J.Y. Reginster, Jean-Yves Reginster, Jean‐Yves Reginster, On behalf of the Group for the Respect of Ethics and Excellence in Science (GREES), P. Papanastasiou

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

University of Liège Georgetown University Georgetown University Medical Center UCLouvain University of Florence

About

J.-Y. Reginster is an author at University of Liège specializing in medicine, orthopaedics, and osteoporosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	9	407
2	Engineering	2	2	77
3	Health Sciences	2	2	49
4	Biomedical Engineering	1	1	12
5	Mechanical Engineering	1	1	65

J.-Y. Reginster

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) René Rizzoli, Steven Boonen, Maria Luisa Brandi, Current Medical Research and Opinion	2013	323
Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials Olivier Bruyère, Karel Pavelká, Lucio C. Rovati, Osteoarthritis and Cartilage Chronic Musculoskeletal ConditionGlucosamine Sulphate TreatmentOsteoarthritisSurgeryJoint Replacement	2007	171
Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium Florent Richy, Margaret L. Gourlay, Philip D. Ross, QJM	2003	129
Recommendations for the registration of drugs used in the treatment of osteoarthritis Maxime Dougados, Jean‐Pierre Devogelaer, M Annefeldt, Ghent University Academic Bibliography (Ghent University)	1996	121
Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications J.J. Body, Pierre Bergmann, Steven Boonen, Osteoporosis International	2012	81
Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin J.-Y. Reginster, D. Denis, Rita Deroisy, Journal of Bone and Mineral Research	1994	68
A FRAX® model for the assessment of fracture probability in Belgium Helena Johansson, J. A. Kanis, E. V. McCloskey, Osteoporosis International Skeletal TraumaFracture ProbabilityFrax® ModelEngineeringMechanics	2010	65
Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study Paul D. Miller, Robert R. Recker, J.-Y. Reginster, Osteoporosis International PharmacotherapyClinical DentistryMedicineMonthly Oral IbandronateOsteoporosis	2011	60
Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis J.-Y. Reginster, F. Bianic, Ross Campbell, Osteoporosis International	2019	51
A 5‐year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium J.-Y. Reginster, L Meurmans, Rita Deroisy, European Journal of Clinical Investigation	1994	43

Page 1